PMID: 11344779May 10, 2001Paper

Stem cell transplantation in systemic sclerosis: rationale and status report

The Israel Medical Association Journal : IMAJ
D E Furst, A Tyndall

Abstract

The rationale for stem cell transplantation is feasible and tests the hypothesis that the immune system is important in the pathogenesis of SSc in carefully selected patients. At the present time, results from pilot studies of SCT in systemic sclerosis are moderately encouraging, although further refinements in SCT treatment protocols are probably necessary. Finally, the time for a controlled study of SCT is rapidly approaching.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.